Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

Sanofi and IGM Biosciences collaborate to develop IgM antibody agonists

Sanofi and IGM Biosciences, Inc. today announced the signing of an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists...

Axsome Therapeutics buys sleep disorder drug from Jazz

Jazz Pharmaceuticals plc on March 28 announced that it has entered into a definitive agreement to divest Sunosi® (solriamfetol) to Axsome Therapeutics. SUNOSI is a...

Sanofi’s rare disease drug gets world’s first approval in Japan

The Japanese Ministry of Health, Labor, and Welfare (MHLW) has granted marketing authorization for Xenpozyme® (olipudase alfa) for the treatment of adult and pediatric...

Visby Medical contracts with BARDA to develop the Flu-COVID rapid all-in-one PCR test for home use

Visby Medical™, a leading medical diagnostic company, announced that it has received an additional $25.5M in federal funding to develop and validate an at-home...

Global Center for Traditional Medicine in India with an investment of $250 million

The World Health Organization (WHO) and the Government of India on 25 March signed an agreement to establish the WHO Global Centre for Traditional...

U.S. FDA approves drug to treat seizures associated with Lennox-Gastaut Syndrome, a rare form of childhood epilepsy

UCB, a global biopharmaceutical company, on Monday announced that FINTEPLA (fenfluramine) oral solution CIV has been approved in the United States, by the U.S....
spot_img

Expert Articles

spot_img